Information on symposiums in 30th Annual Meeting (Tokyo) programed by JSSX DIS (Directors Initiative Session) has been updated. The registration is now open.
The 30th Annual Meeting (Tokyo) will include various symposiums, distinguished lectures and others programed by JSSX DIS (Directors Initiative Session) shown below. Please visit to website of 30th Annual Meeting for your registration. The dead line of early-bird registration is September 24, 2015.
- Toxicology DIS
•Symposium 11 ”In Vitro Screening” on November 13 (Fri) 9:30~
•Symposium 16 ”Evaluation and current status of the causal relationship of adverse drug events” on November 14 (Sat) 9:30~ - PKPD-QSP DIS
•Distinguished Lecture 2 ”Quantitative Systems Pharmacology (QSP) in Translational Drug Discovery & Development” on November 13 (Fri) 13:30~
•Symposium 15 ”Quantitative Systems Pharmacology on Drug Development and Discovery Research” on November 14 (Sat) 9:30~
•QSP Seminar ”QSP round table discussion” on November 14 (Sat) 13:15~ - Clinical Pharmacology DIS
•Symposium 6 ”UP-to-date trends and advances in clinical pharmacology research using pharmacokinetic information” on November 12 (Thr) 15:00~ - In silico & Screening Technology DIS
Symposium18 ”The frontline of ADME related screening and in silico technology” on November 14 (Sat) 13:15~ - Analysis DIS
•Symposium 9 on November 13日（金）9:30~
•Symposium 14 ”Recent Progress of the biologics analysis” on November 14 (Sat) 9:30~ - Drug Metabolizing Enzyme DIS
•Symposium 1 ”Current Trends and Issues of Drug Metabolism Researches in Pharmaceutical Companies: Inspire future studies in Academia and Industry to facilitate drug development” on November 12 (Thr) 9:30~
•Symposium 7 ”New breakthrough technologies for drug metabolism study” on November 12 (Thr) 15:00~
•Symposium 10 ”Significance of non-P450 drug-metabolizing enzymes: from basic science to drug development” on November 13 (Fri) 9:30~ - Transporter DIS
•Symposium 4 ”Unexpected observation related to transporters found during drug development” on November 12 (Thr) 9:30~ - Regulation DIS
•Symposium 17 ” Practical evaluation of drug interactions in drug development” on November 14 (Sat) 13:15~ - Biomarker DIS
•Symposium 9 on November 13 (Fri) 9:30~
•Symposium 13 ”Innovation in Cancer Treatment” on November 14 (Sat) 9:30~ - Biologics DIS
•Symposium 3 ”Current situation of the functionalized antibody development” on November 12 (Thr) 9:30~
•Symposium 5 ”Pharmacokinetics/pharmacodynamics of antibody pharmaceuticals” on November 12 (Thr) 15:00~
•Symposium 14 ”Recent Progress of the biologics analysis” on November 14 (Sat) 9:30~ - Disease Research on the Frontiers DIS
•Symposium 2 ” Connection of DMPK research to current research in kidney disease” on November 12 (Thr) 9:30~
•Symposium 13 ”Innovation in Cancer Treatment” on November 14 (Sat) 9:30~ - DDS (drug delivery system) DIS
•Symposium 8 TBC on November 12 (Thr) 15:00~